Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Masahide Yamazaki"'
Autor:
Ai Fujii, Yuto Matsuda, Tomohisa Yabe, Hayashi Norifumi, Keiji Fujimoto, Masahide Yamazaki, Hitoshi Yokoyama, Kengo Furuichi
Publikováno v:
Journal of Medical Case Reports, Vol 18, Iss 1, Pp 1-3 (2024)
Abstract Background Rectus sheath hematoma is a rare presentation often associated with abdominal trauma and anticoagulant therapy. Here, we present a patient with severe rectus sheath hematoma accompanied by nephrotic syndrome who achieved significa
Externí odkaz:
https://doaj.org/article/85e2d61ec5164ed6b205108eb598b2c7
Publikováno v:
Clinical Case Reports, Vol 12, Iss 3, Pp n/a-n/a (2024)
Key Clinical Message The present case indicates that cryoglobulinemia vasculitis should be considered in the differential diagnosis of purpura in patients with adult‐onset Still's disease (AOSD). Abstract The presence of purpura is suggested in adu
Externí odkaz:
https://doaj.org/article/66c241e81c294339988b0d0f2ec7183b
Autor:
Noriharu Nakagawa, Masahide Yamazaki
Publikováno v:
Clinical Case Reports, Vol 11, Iss 2, Pp n/a-n/a (2023)
Abstract The leukemic phase of ALK‐positive anaplastic large cell lymphoma (ALCL) is reported to have a poor prognosis. We, herein, report a rare case of the common type of ALK‐positive ALCL complicated by lactic acidosis.
Externí odkaz:
https://doaj.org/article/448b19abd2a4490fb38be5b8347769c9
Autor:
Noriharu Nakagawa, Masahide Yamazaki
Publikováno v:
Clinical Case Reports. 11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::679f1dbe42fab50c899c639d726989f1
https://doi.org/10.1002/ccr3.6948
https://doi.org/10.1002/ccr3.6948
Publikováno v:
Clinical journal of gastroenterology. 15(4)
Chemoradiotherapy regimens for patients with esophageal cancer intolerant to standard therapies remain to be established. The standard therapy for patients with stage II-III esophageal squamous cell carcinoma, who are not surgical candidates, is defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcd83070b34777d49c62dc583a6d4042
https://pubmed.ncbi.nlm.nih.gov/35461381
https://pubmed.ncbi.nlm.nih.gov/35461381
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 65:882-886
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5dd63a9420358aab685de33acea96ec6
https://doi.org/10.3925/jjtc.65.882
https://doi.org/10.3925/jjtc.65.882
Autor:
Seiji Kojima, Satoru Miyano, Tomohiro Morio, Carola G. Vinuesa, Masahide Yamazaki, Kenichi Yoshida, Elizabeth da Silva, Gaetan Burgio, Hirokazu Kanegane, Hidenori Ohnishi, Bahar Miraghazadeh, Takaki Asano, Zenichiro Kato, Akihiro Hoshino, Rochna Chand, Miyuki Tsumura, Matthew A. Field, Satoshi Okada, Yusuke Okuno, T. Daniel Andrews, Seishi Ogawa, Kay Tanita, Chelisa Cardinez, Matthew C. Cook
Publikováno v:
Journal of Experimental Medicine. 215:2715-2724
Genetic mutations account for many devastating early onset immune deficiencies. In contrast, less severe and later onset immune diseases, including in patients with no prior family history, remain poorly understood. Whole exome sequencing in two coho
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5bcce316f27aa7ddba7dfab0aeb1e1e9
https://doi.org/10.1084/jem.20180639
https://doi.org/10.1084/jem.20180639
Autor:
Chelisa, Cardinez, Bahar, Miraghazadeh, Kay, Tanita, Elizabeth, da Silva, Akihiro, Hoshino, Satoshi, Okada, Rochna, Chand, Takaki, Asano, Miyuki, Tsumura, Kenichi, Yoshida, Hidenori, Ohnishi, Zenichiro, Kato, Masahide, Yamazaki, Yusuke, Okuno, Satoru, Miyano, Seiji, Kojima, Seishi, Ogawa, T Daniel, Andrews, Matthew A, Field, Gaetan, Burgio, Tomohiro, Morio, Carola G, Vinuesa, Hirokazu, Kanegane, Matthew C, Cook
Publikováno v:
The Journal of Experimental Medicine
A novel germline missense mutation in human IKBKB (encoding IKK2) confers gain of function and results in a combined immune deficiency syndrome. A mouse model engineered by CRISPR/Cas9 to carry the orthologous mutation exhibits a similar cellular phe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::f70108ec93bd35068b0769cf6dc4a277
https://pubmed.ncbi.nlm.nih.gov/30337470
https://pubmed.ncbi.nlm.nih.gov/30337470
Publikováno v:
Haigan. 54:218-225
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d8f9e353e99f53c5f77dc83deec04f54
https://doi.org/10.2482/haigan.54.218
https://doi.org/10.2482/haigan.54.218
Autor:
Masahide Yamazaki
Publikováno v:
Annals of Oncology. 30:vi122
Background It is well known that secondary MDS is refractory to treatment. In general, high-risk MDS is treated with AZA, but its effect is often delayed. I experienced a case which has rapidly improved to the ET from secondary MDS after 2 courses of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9356a8a2004237f6391e673322029fa3
https://doi.org/10.1093/annonc/mdz343.021
https://doi.org/10.1093/annonc/mdz343.021